Jeffrey L. Edwards's Insider Trades & SAST Disclosures
Jeffrey L. Edwards's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 308 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey L. Edwards.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. ... | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 308 | 308 | - | - | Restricted Stock Units | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 30,000 | 79,667 (0%) | 0% | - | Common Stock | |
| Clearside Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | L. Edwards Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | L. Edwards Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 49,667 (0%) | 0% | - | Common Stock | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 12,666 | 12,666 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 8,289 | 41,866 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 07 Jun 2023 | 4,624 | 33,977 (0%) | 0% | 17.5 | 80,966 | Common Stock |
| FibroGen Inc | Jeffrey L. Edwards | Director | Sale of securities on an exchange or to another person at price $ 16.74 per share. | 07 Jun 2023 | 3,265 | 38,601 (0%) | 0% | 16.7 | 54,656 | Common Stock |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 18,182 | 40,113 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 21,931 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 9,554 | 9,554 | - | - | Restricted Stock Unit | |
| Clearside Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,684 | 25,684 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,777 | 33,577 (0%) | 0% | 0 | Common Stock | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2022 | 7,059 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 9.50 per share. | 04 Jun 2022 | 7,059 | 12,457 (0%) | 0% | 9.5 | 67,061 | Common Stock |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 9,474 | 9,474 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2021 | 5,398 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 9.77 per share. | 14 Oct 2021 | 5,398 | 5,398 (0%) | 0% | 9.8 | 52,738 | Common Stock |
| Clearside Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 7,059 | 7,059 | - | - | Restricted Stock Unit | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 4,700 | 17,800 (0%) | 0% | 0 | Common Stock | |
| Lifecore Biomedical Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2020 | 5,398 | 5,398 | - | - | Restricted Stock Unit | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 4,700 | 13,100 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges